Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea-U.S. Free Trade Agreement Likely To Put Stranglehold On Local Korean Drug Makers

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korean pharmaceutical companies are bracing for a tough time ahead if the governments of South Korea and the U.S. ratify a long-awaited Free Trade Agreement hammered out last year after eight rounds of negotiations between the two countries
Advertisement

Related Content

Merck Signs Wide-Ranging MOU To Help Beef Up Korea's Global R&D Capabilities
U.S. And South Korean Presidents Say More Negotiation Needed To Ratify Free Trade Agreement But Pharma Provisions Seen Intact
Korea-EU Free Trade Agreement Creates Another Threat To Local Korean Pharmas; Good For MNCs
U.S. Trade Rep’s IP Report: China Always Improving, Never Enough
South Korea To Implement cGMPs On OTC Drugs To Prepare For U.S. Free Trade Agreement
Korean Drug Makers Caught Between GMPs And FTA To Compete Globally
Disputes Between South Korean Local Drug Makers And Multinationals Increasing, Expected To Get Worse
Disputes Between South Korean Local Drug Makers And Multinationals Increasing, Expected To Get Worse
Critics Say S. Korea Drug Makers Need To Add Innovative Drugs
South Korea to Pump US$1 Bln Into Drug Sector to Brace for FTAs (South Korea)
Advertisement
UsernamePublicRestriction

Register

SC067135

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel